WAYNE, Pa., Nov. 14, 2014 /PRNewswire/ -- Ryan & Maniskas, LLP has commenced an investigation into potential securities law violations by certain officers of Vascular Solutions Inc. ("Vascular Solutions" or the "Company") (NASDAQ: VASC).
Vascular Solutions shareholders who purchased Vascular Solutions shares should contact Richard A. Maniskas, Esquire at 877-316-3218 or at [email protected] to learn more about this investigation or visit: www.rmclasslaw.com/cases/vasc.
On November 13, 2014, the U.S. Department of Justice filed a criminal indictment in the United States District Court for the Western District of Texas related to the Vari-Lase Short Kit investigation. The indictment alleges that Vascular Solutions and its Chief Executive Officer introduced adulterated and misbranded medical devices into interstate commerce, and conspired to introduce such adulterated and misbranded products to the market.
On this news, shares of Vascular Solutions fell $6.76 per share, or more than 22.16%, to close at $23.74 per share on November 14, 2014.
If you own Vascular Solutions shares and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free: (877) 316-3218 or visit: www.rmclasslaw.com/cases/vasc. You may also email Mr. Maniskas at [email protected]. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.
SOURCE Ryan & Maniskas, LLP